Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Argireline structure

Argireline

Cosmetic & Sexual
Phase 3 Research
60%
Low Risk
1/5

Warnings

Limited penetration - topical effects only
Large molecular weight limits absorption
Not a replacement for Botox

Contraindications

Broken SkinActive Skin Infections

Possible Side Effects

Skin IrritationRedness

Legal & Regulatory

FDA Status Research Only
WADA Status Not Prohibited
Prescription Not Required

Pregnancy

Not Rated